Article
28 March 2025 - by Daniel Perlman, Les Kartchner, Brent Jensen
Our research shows that lower-cost groups moving to the level-funded market will likely result in higher costs for those remaining in the ACA small group market.
Video
19 March 2025 - by Logan Blank, Nick Gipe, Jordan Hull, Les Kartchner
Article
19 March 2025 - by Daniel Perlman, Les Kartchner, Brent Jensen
With multiple health plan funding options available to small employers, we analyze the impact of shifts to level-funded plans.
Video
20 March 2024 - by Jeremy Sarich, John Rogers, Les Kartchner, Michelle (Klein) Robb
As midnight on June 3 approaches, many plans face considerable uncertainties relating to the Inflation Reduction Act’s benefit redesign, Medicare Prescription Payment Plan, and changes from the Advance Notice.
Article
07 September 2023 - by Les Kartchner, Aleece Blake
We explore the costs and outcomes of maternity care in the United States, and outline a strategic data-driven road map for health plans to address these issues.
Video
06 September 2023 - by Hayley M. Rogers, Bryce Platt, Les Kartchner, Emily Vandermause
In this webinar we take a dive into the latest changes by CMS to the Medicare Advantage star ratings programs.
Article
23 June 2023 - by Dustin Grzeskowiak, Eleanor Hill, Les Kartchner, Shelley Moss
Milliman DEPTH is a data-driven and visually dynamic tool that transforms medical and prescription drug claims data into actionable insights accessible via a user-friendly dashboard.
Video
09 November 2022 - by Hayley M. Rogers, Lisa Mattie, Les Kartchner, Greg Sgrosso
Whether you are new to the Medicare Advantage field or are looking to increase your current Medicare revenue and marketing power, CMS STAR ratings play a critical role in the bid process and the long-term success of your plan.
Article
10 November 2021 - by Brent Jensen, Les Kartchner
How should employers evaluate opportunities as the number and variety of point solutions in the health and group benefits market continues to grow?
Article
28 December 2020 - by Les Kartchner, Brent Jensen
What are some considerations for employers as new COVID-19 vaccines are made available?